Craig S. Stern
Craig S. Stern publishes mostly in Economics and Econometrics, Cardiology and Cardiovascular Medicine and General Health Professions, on topics such as Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices and Healthcare Policy and Management.
- World rank
- #7,448,283 of 7,710,434 ranked researchers
- Rank in New Zealand
- #20,918 of 21,128
- Works
- 36
- Citations
- 75
- Citations per work
- 2.1
What does Craig S. Stern research?
Craig S. Stern's work is mostly in Medicine (29%), Economics, Econometrics and Finance (11%), Health Professions (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1951.8%
- Health Sciences1336.8%
- Medicine1129.2%
- Health Professions37.6%
- Social Sciences411.4%
- 1Economics and Econometrics11% of their works
- 2Cardiology and Cardiovascular Medicine11% of their works
- 3General Health Professions8% of their works
- 4Geriatrics and Gerontology8% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Pediatrics, Perinatology and Child Health5% of their works
Research topics
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Healthcare Policy and Management
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biomedical Ethics and Regulation
- Pesticide Residue Analysis and Safety
- Biochemical Acid Research Studies
Which keywords describe Craig S. Stern's research?
The keywords of their largest research topics: Clinical Trials, Inappropriate Medication Use, Polypharmacy, Off-Label Drug Use, Pediatric Pharmacokinetics, Cost-effectiveness Analysis, Drug Development Costs and Generic Drugs.
- Pesticide Residues
- Lipoic Acid
- Regulatory Challenges
- Insurance Markets
- Generic Drugs
- Cost-effectiveness Analysis
- Off-Label Drug Use
- Inappropriate Medication Use
- Clinical Trials
- Polypharmacy
- Pediatric Pharmacokinetics
- Drug Development Costs
- Health Care Spending
- Quality of Life
- Stem Cell Regulation
- Liquid Chromatography
- Pyruvate Dehydrogenase Complex
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Clinical Trials62 topics
- Inappropriate Medication Use61 topic
- Polypharmacy61 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Cost-effectiveness Analysis31 topic
- Drug Development Costs31 topic
- Generic Drugs31 topic
- Health Care Spending31 topic
- Insurance Markets31 topic
- Quality of Life31 topic
- Regulatory Challenges21 topic
- Stem Cell Regulation21 topic
- Lipoic Acid11 topic
- Liquid Chromatography11 topic
- Pesticide Residues11 topic
- Pyruvate Dehydrogenase Complex11 topic
Where does Craig S. Stern work?
Craig S. Stern's main affiliation in the publication record is Pharmac, New Zealand.
How many publications and citations does Craig S. Stern have?
OpenAlex counts 36 works and 75 citations for Craig S. Stern, an h-index of 4, ranking #7,448,283 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Craig S. Stern. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.